MAPK8 and cancer: Recent findings have identified the pro-tumorigenic role JNK-signaling module in many cancers [21, 35–37] in addition to establishing the efficacy of JNK inhibitors in suppressing cancer cell growth in vitro and in vivo [20, 38–40].